...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Free
Message: Low Impact Journals

One thing that is bothering me a lot as I research Resverlogix is the journals their research is published in is the bottom tier of journals; at least from 2017. See below.

Can anyone else comment on the quality of their research and researchers. TIA


The Journal Citation Reports (JCR) database tracks all impact factors for 12,061 journals.  0nly 213 journal titles, or 2% of the journals tracked by JCR, have a 2016 impact factor of 10 or higher.  The top 5% of journals have impact factors approximately equal to or greater than 6 (553 journals or 4.6% of the journals tracked by JCR).  Approximately two-thirds of the journals tracked by JCR have a 2016 impact factor equal to or greater than 1.


 


RVX PUBLISHED REASEARCH SINCE 20)17


1.Atherosclerosis/Impact factor 4.239

2. American Journal of Cardiovascular Drugs ..... Impact Factor 2.741;

3.  Kidney and Blood Pressure Research

 Current Impact Factor: 3.

4. Kidney International    Impact Factor is 3.357 ...

5. Molecular Pharamcology 2017 impact factor of 3.987.

6. Journal of Cardiovascular Translational Research/Impact factor 2.319

 

 

4
Apr 15, 2019 04:34PM
2
Apr 15, 2019 08:10PM
Share
New Message
Please login to post a reply